Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Study Designs in Epidemiology

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Siphoviridae</i> phage tails co-enrich with ex vivo amyloids.

bioRxiv : the preprint server for biology·2026

Same author

Helical reconstruction of amyloids in cryoSPARC.

Acta crystallographica. Section F, Structural biology communications·2026

Same author

Three-Dimensional Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion.

Journal of the American Heart Association·2026

Same author

Efficacy of a Moisture-Wicking, Silver-Impregnated Textile in Hospitalized Patients With Intertriginous Dermatitis (ITD): A Single-Case Experiment.

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society·2026

Same author

3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion.

bioRxiv : the preprint server for biology·2026

Same author

Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-β PET Drugs for Selection of Patients for Amyloid-β-Directed Therapies and Other Labeling Updates.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

A regulatory view on adaptive/flexible clinical trial design.

H M James Hung¹, Robert T O'Neill, Sue-Jane Wang

¹Division of Biometrics I, OB/OTS/CDER/FDA, Rockville, MD, USA. hsienming.hung@fda.hhs.gov

Biometrical Journal. Biometrische Zeitschrift

|September 16, 2006

Summary

Adaptive and flexible trial designs are gaining traction in pharmaceutical development. While statistical methods are advancing, significant challenges remain in methodology, application, efficiency, and regulatory evaluation.

Related Experiment Videos

Last Updated: Jul 20, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

Pharmaceutical development
Clinical trial methodology
Regulatory science

Background:

Growing interest in adaptive and flexible clinical trial designs for pharmaceutical product development.
Significant advancements in statistical methodology for these innovative designs.
Existing literature highlights important issues in methodology and application.

Purpose of the Study:

To discuss challenges associated with adaptive and flexible trial designs.
To highlight practical considerations beyond statistical methodology.
To share insights based on limited regulatory experience.

Main Methods:

Review of current statistical methodologies for adaptive designs.
Discussion of practical challenges in trial conduct and logistics.
Analysis of infrastructure requirements for adaptive trials.

Main Results:

Identified key issues in the application of adaptive design methodology.
Highlighted challenges in overall development program efficiency.
Noted difficulties in regulatory evaluation of adaptive trial results and conduct.

Conclusions:

Despite statistical advancements, significant practical and regulatory hurdles exist for adaptive designs.
Limited regulatory experience necessitates careful consideration of implementation.
Further research and guidance are needed to overcome these challenges.